Skip to content
value.today

Johnson & Johnson vs Vaxxinity, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Johnson & Johnson is the larger company by market value: $652.5 B against $95 M for Vaxxinity, Inc., 6868 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for Vaxxinity, Inc.). Vaxxinity, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
  • Johnson & Johnson had more revenue: $94.2 B in the year to December 2025 against $0 M for Vaxxinity, Inc. in the year to December 2021.
  • Johnson & Johnson made a net profit of $26.8 B, while Vaxxinity, Inc. made a net loss of $137 M.
  • Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -228333.3% for Vaxxinity, Inc.

Market value, the same start = 100

From Jan 2022: how each one's value moved, whatever its size.

036711071422023202420252026Johnson & Johnson 142Vaxxinity, Inc. 13

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$24B$47B$71B$94B20182019202020212022202320242025Johnson & Johnson $94B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureJohnson & Johnson
JNJ · #24 in the world
Vaxxinity, Inc.
VAXX
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryPharmaceutical—
Founded1886—
Size
Market cap$652.5 B$95 M*
Revenue$94.2 B$0 M
Net income$26.8 B▲ best$-137 M
Employees138,200—
Valuation
P/E ratio40.5×—
Price to sales6.6×—
Price to book8.0×—
Free cash flow yield3.0%—
Altman Z-score zone——
Data as ofMarket cap Oct 2026Market cap Jan 2024

Questions and answers#

Which is bigger, Johnson & Johnson or Vaxxinity, Inc.?

Johnson & Johnson is the larger company by market value: $652.5 B against $95 M for Vaxxinity, Inc., 6868 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for Vaxxinity, Inc.). Vaxxinity, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Which makes more money, Johnson & Johnson or Vaxxinity, Inc.?

Johnson & Johnson had more revenue: $94.2 B in the year to December 2025 against $0 M for Vaxxinity, Inc. in the year to December 2021. Johnson & Johnson made a net profit of $26.8 B, while Vaxxinity, Inc. made a net loss of $137 M.

Which is more profitable, Johnson & Johnson or Vaxxinity, Inc.?

Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -228333.3% for Vaxxinity, Inc.